Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
11 hours ago•Business Today
12 hours ago•Economic Times
12 hours ago•Bloomberg Quint
Final • Div/Share: ₹ 3
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)". | Download
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)". | Download